Literature DB >> 2978112

Bactericidal activity of M14659 enhanced in low-iron environments.

H Mochizuki1, H Yamada, Y Oikawa, K Murakami, J Ishiguro, H Kosuzume, N Aizawa, E Mochida.   

Abstract

The bactericidal activity of M14659 against Escherichia coli in low-iron environments was investigated and compared with that of ceftriaxone and ceftazidime. The bactericidal activity of M14659 against E. coli in Mueller-Hinton broth was enhanced 30- to 20,000-fold by addition of transferrin, which is an iron-binding protein, whereas the activity of ceftriaxone or ceftazidime was much less strongly affected. This enhancement by transferrin was completely inhibited by saturating the iron-binding capacity of transferrin with FeCl3. M14659 was taken up markedly into bacterial cells in the presence of transferrin, and its uptake was inhibited by the protonophore dinitrophenol, which inhibits active-transport systems coupled to an energized membrane such as the iron transport systems of E. coli. The bactericidal activity of M14659, which chelates Fe3+, was also enhanced in the presence of other iron-binding compounds such as lactoferrin and alpha,alpha'-dipyridyl or in iron-deficient Mueller-Hinton broth (Fe3+ concentration, less than 2 nM) supplemented with FeCl3 at 0.1 to 1.0 microM, but not in unsupplemented iron-deficient Mueller-Hinton broth. The E. coli used in this study was confirmed to derepress iron transport systems in the presence of transferrin, lactoferrin, and alpha,alpha'-dipyridyl and in the iron-deficient Mueller-Hinton broth supplemented with FeCl3 at 0 to 1.0 microM. M14659 also showed an excellent antibacterial activity in vitro against other gram-negative bacteria in the low-iron environments. These findings indicate that M14659 may be actively taken up with Fe3+ into bacterial cells, probably through the iron transport systems under conditions of low iron and, thus, kills bacteria effectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2978112      PMCID: PMC175946          DOI: 10.1128/AAC.32.11.1648

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Mechanism of action of agents which uncouple oxidative phosphorylation: direct correlation between proton-carrying and respiratory-releasing properties using rat liver mitochondria.

Authors:  J Cunarro; M W Weiner
Journal:  Biochim Biophys Acta       Date:  1975-05-15

Review 2.  Role of iron in bacterial infection.

Authors:  J J Bullen; H J Rogers; E Griffiths
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

Review 3.  Iron and infection.

Authors:  E D Weinberg
Journal:  Microbiol Rev       Date:  1978-03

Review 4.  Microbial iron compounds.

Authors:  J B Neilands
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

Review 5.  Iron transport and storage proteins.

Authors:  P Aisen; I Listowsky
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

6.  Antibacterial and pharmacokinetic properties of M14659, a new injectable semisynthetic cephalosporin.

Authors:  H Mochizuki; Y Oikawa; H Yamada; S Kusakabe; T Shiihara; K Murakami; K Kato; J Ishiguro; H Kosuzume
Journal:  J Antibiot (Tokyo)       Date:  1988-03       Impact factor: 2.649

7.  Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin.

Authors:  B E Holbein
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

8.  Involvement of outer membrane proteins in enterochelin-mediated iron uptake in Escherichia coli.

Authors:  S Ichihara; S Mizushima
Journal:  J Biochem       Date:  1977-03       Impact factor: 3.387

9.  Iron-controlled infection with Neisseria meningitidis in mice.

Authors:  B E Holbein
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

Review 10.  Antimicrobial properties of iron-binding proteins.

Authors:  A Bezkorovainy
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

View more
  17 in total

1.  In vitro antibacterial activity of KP-736, a new cephem antibiotic.

Authors:  T Maejima; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

2.  Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa.

Authors:  J Trias; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

3.  In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin.

Authors:  M E Erwin; R N Jones; M S Barrett; B M Briggs; D M Johnson
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

4.  Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tonB-dependent iron transport system.

Authors:  P Silley; J W Griffiths; D Monsey; A M Harris
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

5.  In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin.

Authors:  R N Jones; M E Erwin
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

6.  In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor.

Authors:  K Nishida; C Kunugita; T Uji; F Higashitani; A Hyodo; N Unemi; S N Maiti; O A Phillips; P Spevak; K P Atchison; S M Salama; H Atwal; R G Micetich
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

7.  Growth of Actinobacillus pleuropneumoniae is promoted by exogenous hydroxamate and catechol siderophores.

Authors:  M S Diarra; J A Dolence; E K Dolence; I Darwish; M J Miller; F Malouin; M Jacques
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792

8.  In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.

Authors:  M Y Kim; J I Oh; K S Paek; Y Z Kim; I C Kim; J H Kwak
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.

Authors:  M Arisawa; Y Sekine; S Shimizu; H Takano; P Angehrn; R L Then
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

10.  Iron transport-mediated antibacterial activity of and development of resistance to hydroxamate and catechol siderophore-carbacephalosporin conjugates.

Authors:  A A Minnick; J A McKee; E K Dolence; M J Miller
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.